Portrait of Ross, Deborah K.

Ross, Deborah K.

U.S. Representative NC-2 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
23
Buys / sells
83% / 17%
Last trade
Jan 27, 2022
Last filing
Feb 19, 2022

Latest disclosed trades

Latest 10 of 23
Ticker Type Traded
MSFT Sell Jan 27, 2022
MSFT Sell Jan 21, 2022
MSFT Sell Jan 4, 2022
IS Buy Dec 31, 2021
AAPL Buy Dec 30, 2021
FB Buy Dec 30, 2021
NEO Buy Dec 30, 2021
GM Buy Dec 30, 2021
DIS Buy Dec 28, 2021
ALB Buy Dec 28, 2021

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Ross, Deborah K. stock trade activity

FilingIQ has indexed 23 congressional stock trade disclosures for Ross, Deborah K.. The most recent disclosed transaction is dated Jan 27, 2022.

Across the full history, 19 purchases and 4 sales have been disclosed under the STOCK Act.

Top tickers traded by Ross, Deborah K.

Frequently asked

How many stock trades has Ross, Deborah K. disclosed?
FilingIQ tracks 23 Periodic Transaction Report disclosures for Ross, Deborah K., with the most recent dated Jan 27, 2022. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Ross, Deborah K. a net buyer or net seller?
Across the disclosed trade history, 19 (83%) were purchases and 4 (17%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Ross, Deborah K. come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.